Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage.

J Clin Med · 2025 · PMC12525289 · PMID 41096183

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Conversely, TIL-negative tumors (Score 0) were more frequent in non-apocrine TNBC (26.0%) compared with TNAC (8.8%), but this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.